Loading clinical trials...
Loading clinical trials...
Detecting Expression Profiles Associated With Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia Patients Without Detectable Tyrosine Kinase Domain Mutations, Using Transcriptomics
Conditions
Interventions
Clariom
Locations
1
United Kingdom
Clinical Research Facility
Sheffield, South Yorkshire, United Kingdom
Start Date
October 1, 2017
Primary Completion Date
May 4, 2018
Completion Date
May 4, 2018
Last Updated
January 6, 2020
Lead Sponsor
Sheffield Children's NHS Foundation Trust
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions